Correction To: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients With Drug-Resistant Epilepsy

CNS Drugs - United Kingdom
doi 10.1007/s40263-019-00653-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Safety and Preliminary Efficacy Analysis of the mTOR Inhibitor Ridaforolimus in Patients With Taxane-Treated, Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2012English

Efficacy of Verapamil as an Adjunctive Treatment in Children With Drug-Resistant Epilepsy: A Pilot Study

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2014English

Long-Term Seizure Outcomes in Patients With Drug Resistant Epilepsy

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2018English

Evaluating the Safety and Efficacy of Nivolumab in Patients With Advanced Hepatocellular Carcinoma: Evidence to Date

OncoTargets and Therapy
OncologyPharmacology
2019English

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients With Mixed Hyperlipidemia

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

A Noninterventional Study Evaluating the Effectiveness and Safety of Lacosamide Added to Monotherapy in Patients With Epilepsy With Partial-Onset Seizures in Daily Clinical Practice: The VITOBA Study

Epilepsia
Neurology
2015English

P.009 Characterizing Drug-Resistant Epilepsy in an Adult Cohort With New-Onset Epilepsy

Canadian Journal of Neurological Sciences
MedicineNeurology
2019English

Linezolid Safety, Tolerability and Efficacy to Treat Multidrug- And Extensively Drug-Resistant Tuberculosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2011English

Bumepamine, a Brain-Permeant Benzylamine Derivative of Bumetanide, Does Not Inhibit NKCC1 but Is More Potent to Enhance Phenobarbital’s Anti-Seizure Efficacy

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy